Latest News - DexCom
Top Corporates Hub
DexCom
Why DexCom (DXCM) Stock Is Falling Today
31.10.2025 17:00
Shares of medical device company DexCom (NASDAQ:DXCM) fell 14.8% in the afternoon session after the company reported underwhelming earnings.
DexCom Shares Fall After Price Target Cuts Following Q3 Results
31.10.2025 16:19
DexCom (DXCM) shares fell nearly 15% in recent Friday trading after multiple brokerages trimmed thei
Why DexCom Stock Is Crashing Today
31.10.2025 16:16
The diabetes equipment provider had a strong quarter, but next year is looking weaker than expected.
DexCom Stock Is the Worst Performer in the S&P 500. Here’s Why.
31.10.2025 14:17
DexCom may be a major player in the market for continuous glucose monitors, but that doesn’t means it’s shielded from concerns over slower-than-expected growth. Interim CEO Jake Leach indicated on DexCom’s third-quarter earnings call Thursday that 2026 revenue growth could miss analysts’ forecasts. While growth is expected to be “certainly in that double-digit range,” Leach said, “the top end of our range is probably slightly below where the Street is today for our base case.”
DXCM Q3 Deep Dive: Margin Pressures Offset Strong Diabetes Access and Product Expansion
31.10.2025 13:10
Medical device company DexCom (NASDAQ:DXCM) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be around $4.64 billion, close to analysts’ estimates. Its non-GAAP profit of $0.61 per share was 7.5% above analysts’ consensus estimates.
Dexcom Stock, Down 13%, Is Haunted By Its 'Surprisingly Cautious' Outlook
31.10.2025 13:02
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.
Dexcom execs say company has fixed G7 quality problems
31.10.2025 10:35
After dealing with a deployment issue with glucose monitors earlier this year, interim CEO Jake Leach said improving customer service has also been a focus for the company.
DexCom Inc (DXCM) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Innovations
31.10.2025 03:02
DexCom Inc (DXCM) reports a robust 22% increase in worldwide revenue, driven by expanded CGM access and strategic market advancements.
DexCom (DXCM) Reports Earnings Tomorrow: What To Expect
29.10.2025 03:03
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know.
ViCentra Strengthens Leadership Team to Accelerate Growth
28.10.2025 08:30
ViCentra, a European medical device company redefining insulin delivery for people with diabetes with the Kaleido insulin patch pump system, today announced two strategic senior leadership appointments following the company's recent $85 million Series D financing. Karen Baxter, former Vice President & General Manager at Dexcom, joins as Senior Vice President of Sales, Europe, and Jay Little, a long-time commercialization and market access executive at Medtronic Diabetes, takes on the newly creat
DexCom Earnings Preview: What to Expect
13.10.2025 15:15
DexCom is scheduled to announce its fiscal third-quarter earnings later this month, and analysts project a double-digit profit rise.
William Blair Maintains Bullish Stance on DexCom (DXCM) Stock
08.10.2025 05:47
DexCom, Inc. (NASDAQ:DXCM) is one of the Best Long Term Growth Stocks to Buy Now. On September 19, William Blair analyst Brandon Vazquez maintained their bullish stance on the company’s stock, giving a “Buy” rating. The analyst’s rating is backed by a combination of factors demonstrating its growth potential despite current concerns. The analyst noted that the MAUDE database, which […]
1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm
07.10.2025 04:35
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
DexCom May Be The Most Underrated Growth Story In Healthcare
06.10.2025 06:39
DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory risks. Learn why DXCM stock is a buy.
United States Continuous Glucose Monitoring (CGM) Market Forecast 2025-2033: Focus on California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, Washington, New Jersey
01.10.2025 11:44
The United States Continuous Glucose Monitoring (CGM) Market is projected to surge from US$ 2.05 billion in 2024 to US$ 4.23 billion by 2033, growing at a CAGR of 8.36% from 2025-2033. Key growth drivers include the rising prevalence of diabetes, technological advancements, enhanced insurance coverage, and increased awareness. Major players like Dexcom, Abbott, and Medtronic lead the market with user-friendly, accurate devices. The integration of CGMs is pivotal for proactive diabetes management
1 Growth Stock Down 40% to Buy Hand Over Fist Right Now
23.09.2025 13:45
It is dealing with some short-term issues, but its prospects remain bright.
Stock Market Today: Dow, S&P Aim For New Highs; Gold Stocks Shine (Live Coverage)
19.09.2025 18:05
Major stock indexes rise Friday as Wall Street awaits news from President Donald Trump's call with China's Xi Jinping.
Why DexCom (DXCM) Shares Are Trading Lower Today
19.09.2025 17:11
Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring device, questioned its accounting, and highlighted an executive exodus.
1 Large-Cap Stock Worth Your Attention and 2 We Find Risky
18.09.2025 05:32
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Wall Street is Bullish on DexCom (DXCM), Here’s Why
16.09.2025 16:42
DexCom, Inc. (NASDAQ:DXCM) is one of the Best NASDAQ Stocks to Buy with Huge Upside Potential. Wall Street is bullish on DexCom, Inc. (NASDAQ:DXCM) after the company topped revenue and EPS estimates during its fiscal second quarter of 2025. The company posted $1.16 billion in revenue, up 15.21% year-over-year and ahead of consensus by $32.49 […]